Elizabeth Cermak

Insider Reports History

Location
Chapel Hill, NC
Signature
/s/ Jonathan Foster by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elizabeth Cermak:

Company Role Class Num Shares Value Price $ Report Date Ownership
Moleculin Biotech, Inc. Director Stock Options (right to buy) 164,668 12 Nov 2025 Direct
Clarus Therapeutics Holdings, Inc. Director Common Stock 5,766 07 Jun 2022 Direct
Clarus Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 4,805 07 Jun 2022 Direct

Insider Reports Filed by Elizabeth Cermak

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MBRX Moleculin Biotech, Inc. 12 Nov 2025 1 $0 4 Director 14 Nov 2025, 16:06
MBRX Moleculin Biotech, Inc. 04 Nov 2024 1 $0 4 Director 06 Nov 2024, 20:05
MBRX Moleculin Biotech, Inc. 25 May 2023 1 $0 4 Director 26 May 2023, 17:16
MBRX Moleculin Biotech, Inc. 20 Jun 2022 2 $0 4 Director 22 Jun 2022, 19:02
CRXT Clarus Therapeutics Holdings, Inc. 07 Jun 2022 2 $0 4 Director 09 Jun 2022, 20:00
CRXT Clarus Therapeutics Holdings, Inc. 12 Dec 2021 2 $0 4 Director 14 Dec 2021, 18:00
CRXT Clarus Therapeutics Holdings, Inc. 09 Sep 2021 0 $0 3 Director 13 Sep 2021, 20:36
MBRX Moleculin Biotech, Inc. 07 Jun 2021 1 $0 4 Director 09 Jun 2021, 16:26